Exacerbations of severe asthma

Clinical and Experimental Allergy

Volumn 42, Issue 5, 2012, Pages 670-677

  Mcdonald, V M ^a,b,d   Gibson, P G ^b,c,d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC ASTHMA; ASTHMA; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ASTHMA; DISEASE PROGRESSION; HUMANS; PHENOTYPE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84859999746     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2012.03981.x     Document Type: Review

References (59)

1. Bahadori K, Doyle-Waters MM, Marra C et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 19:24.
2. Heaney LG, Brightling CE, Menzies-Gow A, Stevenson M, Niven RM, British Thoracic Society Difficult Asthma Network. Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry. Thorax 2010; 65:787-94.
3. Moore WC, Bleecker ER, Curran-Everett D et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119:405-13.
4. FitzGerald JM Targeting lung attacks. Thorax 2011; 66:365-6.
5. Vincent SD, Toelle BG, Aroni RA, Jenkins CR, Reddel HK Exasperations" of asthma: a qualitative study of patient language about worsening asthma. Med J Aust 2006; 184:451-4.
6. Bush A, Pavord I Following Nero: fiddle while Rome burns, or is there a better way? Thorax 2011; 66:367.
7. Bousquet J, Mantzouranis E, Cruz AA et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126:926-38.
8. Boulet LP Influence of comorbid conditions on asthma. Eur Respir J 2009; 33:897-906.
9. Heaney LG, Conway E, Kelly C et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 2003; 58:561-6.
10. Gibson PG, Taramarcaz P, McDonald VM Use of omalizumab in a severe asthma clinic. Respirology 2007; 12(Suppl. 3):S35-44.
11. McDonald VM, Vertigan AE, Gibson PG How to set up a severe asthma service. Respirology 2011; 16:900-11.
12. Reddel HK, Taylor DR, Bateman ED et al. An official American thoracic society/European respiratory society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59-99.
13. Leidy NK, Wilcox TK, Jones PW et al. Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health 2010; 13:965-75.
14. Turner RM, Hayen A, Macaskill P, Irwig L, Reddel HK Control charts demonstrated limited utility for the monitoring of lung function in asthma. J Clin Epidemiol 2012; 65:53-61.
15. Thamrin C, Zindel J, Nydegger R et al. Predicting future risk of asthma exacerbations using individual conditional probabilities. J Allergy Clin Immunol 2011; 127:1494-502.
16. Federman AD, Wisnivesky JP, Wolf MS, Leventhal H, Halm EA Inadequate health literacy is associated with suboptimal health beliefs in older asthmatics. J Asthma 2010; 47:620-6.
17. Rosenfeld L, Rudd R, Emmons KM, Acevedo-García D, Martin L, Buka S Beyond reading alone: the relationship between aural literacy and asthma management. Patient Educ Couns 2011; 82:110-6.
18. Wenzel SE Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368:804-13.
19. Wang F, He XY, Baines KJ et al. Different inflammatory phenotypes in adults and children with acute asthma. Eur Respir J 2011; 38:567-74.
20. Lasserson TJ, Ferrara G, Casali L Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database Syst Rev 2011; 12:CD004106.
21. Bousquet J, Cabrera P, Berkman N et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 2005; 60:302-8.
22. Fairs A, Agbetile J, Hargadon B et al. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med 2010; 182:1362-8.
23. Denning DW, O'Driscoll BR, Powell G et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am J Resp Crit Care Med 2009; 179:11-8.
24. Haldar P, Brightling CE, Hargadon B et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973-84.
25. Green RH, Brightling CE, McKenna S et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 30:1715-21.
26. Powell H, Murphy VE, Taylor DR et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011; 378:983-90.
27. Nair P, Pizzichini MM, Kjarsgaard M et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360:985-93.
28. Moore WC, Meyers DA, Wenzel SE et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181:315-23.
29. Haldar P, Pavord ID, Shaw DE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178:218-24.
30. Holguin F, Bleecker ER, Busse WW et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol 2011; 127:1486-93.
31. Scott HA, Gibson PG, Garg ML, Wood LG Airway inflammation is augmented by obesity and fatty acids in asthma. Eur Respir J 2011; 38:594-602.
32. Wood LG, Scott HA, Garg ML, Gibson PG Innate immune mechanisms linking non-esterified fatty acids and respiratory disease. Prog Lipid Res 2009; 48:27-43.
33. Tattersfield AE, Postma DS, Barnes PJ et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999;160:594-9
34. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310:1225-9.
35. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002;324:763.
36. Wark PA, Johnston SL, Bucchieri F et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201:937-47.
37. Contoli M, Message SD, Laza-Stanca V et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006; 12:1023-6.
38. Forbes RL, Gibson PG, Murphy VE, Wark PA Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma. Thorax 2012; 67:209-14.
39. Wood LG, Powell H, Grissell TV et al. Persistence of rhinovirus RNA and IP-10 gene expression after acute asthma. Respirology 2011; 16:291-9.
40. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002; 19:68-75.
41. Bullens DMA, Decraene A, Dilissen E et al. Type III IFN-λ mRNA expression in sputum of adult and school-aged asthmatics. Clin Exp Allergy 2008; 38:1459-67.
42. Suptawiwat O, Tantilipikorn P, Boonarkart C et al. Enhanced susceptibility of nasal polyp tissues to avian and human influenza viruses. PLoS ONE 2010; 5:e12973.
43. Wood LG, Simpson JL, Wark PA, Powell H, Gibson PG Characterization of innate immune signalling receptors in virus-induced acute asthma. Clin Exp Allergy 2011; 41:640-8.
44. Beigelman A, Mikols CL, Gunsten SP, Cannon CL, Brody SL, Walter MJ Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis. Respir Res 2010; 11:90.
45. Rowe BH, Sevcik W, Villa-Roel C Management of severe acute asthma in the emergency department. Curr Opin Crit Care 2011; 17:335-41.
46. Thamrin C, Nydegger R, Stern G et al. Associations between fluctuations in lung function and asthma control in two populations with differing asthma severity. Thorax 2011; 66:1036-42.
47. Wood LG, Powell H, Grissell T et al. Persistent airway obstruction after virus infection is not associated with airway inflammation. Chest 2007; 131:415-23.
48. Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med 2010; 182:627-32.
49. Chang AB, Clark R, Acworth JP, Petsky HL, Sloots TP The impact of viral respiratory infection on the severity and recovery from an asthma exacerbation. Pediatr Infect Dis J 2009; 28:290-4.
50. Triasih R, Duke T, Robertson CF Outcomes following admission to intensive care for asthma. Arch Dis Child 2011; 96:729-34.
51. Bai TR, Vonk JM, Postma DS, Boezen HM Severe exacerbations predict excess lung function decline in asthma. Eur Respir J 2007; 30:452-6.
52. O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW, START Investigators Group. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009; 179:19-24.
53. Chung KF, Bel EH, Wenzel SE Difficult-to-treat severe asthma. Eur Respir Mon 2011; 51:15.
54. Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 1993; 342:1032-6.
55. Gibson PG, McDonald VM, Marks GB Asthma in the older adult. Lancet 2010; 374:803-13.
56. Gamble J, Stevenson M, McClean E, Heaney LG The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009; 180:817-22.
57. Williams LK, Peterson EL, Wells K et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol 2011; 128:1185-91.
58. McDonald VM, Higgins I, Wood LG, Gibson PG Multidimensional assessment and individualised management of obstructive airway diseases (OAD) in older adults. Respirology 2011; 16:13.
59. Hargreave FE, Nair P The definition and diagnosis of asthma. Clin Exp Allergy 2009; 39:1652-8.